Pharmacokinetics of trimethoprim-sulphamethoxazole in two-day-old foals after a single intravenous injection.

Six healthy two-day-old foals (3 pony foals and 3 horse foals) were given a single intravenous (iv) injection of trimethoprim (TMP)--sulphamethoxazole (SMZ) at a dosage of 2.5 mg of TMP/kg bodyweight (bwt) and 12.5 mg of SMZ/kg bwt. Serum TMP and SMZ concentrations were measured serially during a 24 hour period. The overall elimination rate constant (K) for TMP in the pony and horse foals was 0.45/h, whereas the K values for SMZ for the pony and horse foals were 0.12/h and 0.07/h, respectively (no significant difference; P greater than 0.05). Based on published minimum inhibitory concentration values for equine pathogens (Adamson et al 1985), the primary indication for the use of TMP/SMZ in foals may be in the treatment of infections caused by gram-positive bacteria. A dosage of 2.5 mg of TMP/kg bwt and 12.5 mg of SMZ/kg bwt, given iv at 12 h intervals would be appropriate.

[1]  T. Vree,et al.  Pharmacokinetics and renal clearance of sulfamethazine, sulfamerazine, and sulfadiazine and their N4-acetyl and hydroxy metabolites in horses. , 1987, American journal of veterinary research.

[2]  R. Ramphal,et al.  Nosocomial infections and bacterial antibiotic resistance in a university equine hospital. , 1986, Journal of the American Veterinary Medical Association.

[3]  W. D. Wilson,et al.  Susceptibility of equine bacterial isolates to antimicrobial agents. , 1985, American journal of veterinary research.

[4]  A. M. Merritt,et al.  Preliminary studies of plasma and extracellular fluid volume in neonatal ponies. , 1984, Equine veterinary journal.

[5]  J. D. Baggot,et al.  Drug disposition in the neonatal animal, with particular reference to the foal. , 1984, Equine veterinary journal.

[6]  B. Brewer,et al.  Clinical and clinicopathological characteristics of the septicaemic neonatal foal: review of 38 cases. , 1984, Equine veterinary journal.

[7]  S. Stover,et al.  Trimethoprim-sulfadiazine in the horse: serum, synovial, peritoneal, and urine concentrations after single-dose intravenous administration. , 1983, American journal of veterinary research.

[8]  T. Divers,et al.  Serum concentrations of trimethoprim and sulfadiazine following oral paste administration to the horse. , 1981, American journal of veterinary research.

[9]  T. Divers,et al.  Experimental induction of Proteus mirabilis cystitis in the pony and evaluation of therapy with trimethoprim-sulfadiazine. , 1981, American journal of veterinary research.

[10]  S. Bushby.  Sulfonamide and trimethoprim combinations. , 1980, Journal of the American Veterinary Medical Association.

[11]  P. Nielsen,et al.  Pharmacokinetics of sulphadoxine and trimethoprim in horses. Half-life and volume of distribution of sulphadoxine and trimethoprim and cumulative excretion of [14C]-trimethoprim , 1979 .

[12]  D. Harrold,et al.  Volume dilution of sodium thiocyanate as a measure of extracellular fluid volume in the horse. , 1979, American journal of veterinary research.

[13]  H. Wesseling.  [Trimethoprim and sulfonamides]. , 1971, Nederlandsch tijdschrift voor geneeskunde.

[14]  W. Vetter,et al.  Trimethoprim metabolites in rat, dog and man: qualitative and quantitative studies. , 1970, Arzneimittel-Forschung.

[15]  S. Bushby,et al.  Trimethoprim and the sulphonamides , 1970, Veterinary Record.